Chairs
- Emily Breidbart
- Sowmya Krishnan
BOD Liaison
Laurie Cohen
Charged with keeping the Society informed on topics about both new and existing drugs and devices. To review problems related to the therapeutics of Pediatric Endocrine disorders and report to the Board of Directors and the greater membership of PES.
Jardiance® (empagliflozin) and Synjardy® (empagliflozin and metformin hydrochlorothiazide)
October 26, 2023
Brief Therapeutic Update from PES Drugs and Therapeutics Committee Jardiance®…
Palovarotene (SohonosTM – Ipsen Pharmaceuticals Inc.)
October 17, 2023
New Meds and Tech from PES Drugs and Therapeutics committee…
iLet® Bionic Pancreas
July 24, 2023
Brief Therapeutic Update from PES Drugs and Therapeutics Committee iLet…